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Abstract 
Recent studies have demonstrated genetic differences between monozygotic (MZ) twins. To 
test the hypothesis that early post-twinning mutational events associate with phenotypic 
discordance, we investigated a cohort of thirteen twin pairs (n=26) discordant for various 
clinical phenotypes using whole-exome sequencing (WES) and screened for copy-number 
variation (CNV). We identified a de novo variant in PLCB1, a gene involved in the 
hydrolysis of lipid phosphorus in milk from dairy cows, associated with lactase non-
persistence, and a variant in the mitochondrial complex I gene MT-ND5 associated with 
amyotrophic lateral sclerosis (ALS). We also found somatic variants in multiple genes 
(TMEM225B, KBTBD3, TUBGCP4, TFIP11) in another MZ twin pair discordant for ALS. 
Based on the assumption that discordance between twins could be explained by a common 
variant with variable penetrance or expressivity, we screened the twin samples for known 
pathogenic variants that are shared and identified a rare deletion overlapping ARHGAP11B, 
in the twin pair manifesting with either schizotypal personality disorder or schizophrenia. 
Parent-offspring trio analysis was implemented for two twin pairs to assess potential 
association of variants of parental origin with susceptibility to disease. We identified a de 
novo variant in RASD2 shared by 8-year-old male twins with a suspected diagnosis of autism 
spectrum disorder (ASD) manifesting as different traits. A de novo CNV duplication was also 
identified in these twins overlapping CD38, a gene previously implicated in ASD. In twins 
discordant for Tourette’s syndrome, a paternally inherited stop loss variant was detected in 
AADAC, a known candidate gene for the disorder.  
Key Words: monozygotic twins; lactose intolerance; ALS; schizophrenia, de novo variants; 
somatic mosaicism. 
 
Introduction 
Twin studies have laid the foundation for exploring the genetics of complex traits and 
common diseases,1 and heritability estimates for conditions such as schizophrenia (0.79),2 
ALS (0.61),3 ASD (0.95)4 and Tourette’s syndrome (0.77).5 The case co-twin design using 
identical twins discordant for a trait or disorder has thrown light on the determinants of health 
and disease and causes of individual differences in normal and abnormal behaviour. Recent 
advancements in DNA sequencing techniques has led to significant methodological 
improvements, allowing the comparison of twin genomes up to the base pair level, which has 
challenged the assumption that MZ twins are genetically identical. 
The underlying genetic differences between co-twins, including single nucleotide variants 
(SNVs), indels, gene conversion, CNVs and postzygotic mitotic recombination, can arise 
during embryonic development. These variations have been proposed as potential genetic 
mechanisms responsible for discordant MZ twins.6 Therefore, comparing the genomes of 
discordant MZ twins signifies a promising opportunity for the search for novel variants 
implicated in disease, which may ultimately narrow the conceptual gap of missing 
heritability. 
Studies of de novo SNVs in parent-offspring trios have identified a mutation rate estimated to 
range between (0.82-1.70) x 10-8 mutations per base per generation.7–9 Post-twinning 
mutations result in somatic mosaicism, a phenomenon defined as two or more genetically 
distinct populations of cells.10 Francioli et al.11 compared 350 validated variants in MZ twins 
and found that ~97% of the variants were germline and ~3% were somatic. In another study, 
an important fraction of de novo mutations presumed to be germline in fact occurred either 
post-zygotically in the offspring, or were inherited because of low-level mosaicism in one of 
the parents.12 The mitotic events during embryogenesis resulting in somatic mosaicism may 
thus play an important and significant role in human disease and MZ twin discordance. 
Postzygotic de novo SNVs and CNVs have been found in MZ twins discordant for a range of 
disorders, including frontometaphyseal dysplasia,13 Dravet’s syndrome,14 Proteus 
syndrome,15 attention problems,16 and schizophrenia,17 
We performed WES and CNV analysis of DNA from thirteen twin pairs discordant for a 
range of complex disorders. For a twin pair discordant for Tourette’s syndrome and another 
pair where both exhibit signs of ASD, we were able to perform parent-offspring trio analysis 
using DNA obtained from the parents. With the aim to identify potential genetic factors that 
influence disease manifestation, it was hypothesised that de novo genetic mechanisms could 
increase the risk of disease onset. To investigate this hypothesis, the burden of rare SNVs, 
indels and CNVs overlapping disease-related genes were analysed.  
Considering the estimated somatic mutation rate is low and that these variants can be 
obfuscated by the relatively high error rate of NGS,18 a highly sensitive filtering method with 
high specificity, sequence resolution and coverage should be implemented. We provide 
evidence for de novo SNVs, indels and CNVs in disease-related genes associated with a 
variety of clinical phenotypes presenting in discordant MZ twins. In addition, the 
identification of potentially pathogenic variants shared by discordant MZ twins, a possibility 
which has been overlooked in earlier studies, suggests phenotypic discordance could be 
explained by a common variant modulated by a secondary genetic or epigenetic mechanism, 
including variants in regulatory regions or modifier genes. 
Materials and Methods 
Sample procurement 
Subjects were thirteen twin pairs discordant for a range of clinical phenotypes (see Table 1 
and Supplementary Material), including the parents of two twin pairs discordant for ASD and 
Tourette syndrome. DNA samples of five of the twin pairs were obtained from the Coriell 
Cell Repository (https://coriell.org/). Peripheral blood and/or buccal samples were collected 
from subjects recruited into the study after obtaining written informed consent. 
Whole-exome sequencing 
WES libraries were prepared with Agilent SureSelect V6 and sequenced on an Illumina 
HiSeq3000 using a 75-bp paired-end reads protocol (see Supplementary Material). 
Sequencing data analysis 
We have an in-house set of approximately six thousand exomes (from controls and rare 
diseases) for cross-checking any shortlisted candidate variants, and sequencing artefacts. 
Sequence alignment to the human reference genome (UCSC hg19), and variant calling and 
annotation were performed with our in-house pipeline. Briefly, this involves alignment with 
NovoAlign, removal of PCR-duplicates with Picard Tools followed by (sample-paired) local 
realignment around indels and germline variant calling with HaplotypeCaller according to the 
Genome Analysis Toolkit (GATK) best practices.19  
Mosaic variants were identified with GATK MuTect2 (version 2.0) and VarScan2 (version 
2.4.3), using each pair as reference to one-another. The raw list of SNVs and indels were then 
filtered using ANNOVAR. 20 Variants in splicing regions, 5’UTR, 3’UTR and protein-coding 
regions, such as missense, frameshift, stop loss and stop gain mutations, were considered. 
Priority was given to rare variants (<1% in public databases, including NHLBI Exome 
Variant Server, Complete Genomics 69 (cg69), Exome Aggregation Consortium (EcAC) and 
1000 Genomes). In silico prediction of pathogenicity was assessed using SIFT,21 
PolyPhen2,22 and MutationTaster.23 Conservation of nucleotides was scored using Genomic 
Evolutionary Rate Profiling (GERP).24 For the parent-offspring trio analyses and detection of 
shared variants, joint genotyping was performed on all samples (n=32). False positive 
variants were removed based on the Variant Quality Score Recalibration (tranche sensitivity 
<99.00), including low quality variants that had low depth of coverage (DP <10) and poor 
genotype quality (GP <20). Potentially pathogenic variants were submitted to the variant 
database LOVD (https://databases.lovd.nl/shared) submission IDs 00207897–00207091 and 
00210051–00210057. 
Variant validation by Sanger sequencing 
DNAs were amplified by polymerase chain reaction (PCR), using primers specific to the 
resulting discordant indels and SNVs (Table 2). Sanger sequencing was performed on an ABI 
3730XL Genetic Analyzer (PE Applied Biosystems, Forest City, CA, USA) to validate the 
variants. Forward and reverse primer sequences for the candidate loci are listed in 
Supplementary Table 3. 
Genome-wide SNP genotyping 
Genotyping was performed according to the manufacturer’s instructions using the Illumina 
HumanCore v12 BeadChip (Illumina Inc., San Diego, CA, USA). In the quality control, 
sample sex and twin zygosity were genotypically confirmed, and no samples were excluded 
based on a genotyping call rate threshold of >0.997. 
Copy number variant detection 
Log R Ratios (LRR) and B-allele frequencies (BAF) were generated using Illumina Genome 
Studio software (v2011.1) and used to call CNVs with PennCNV.25 CNV calling was 
performed following the standard protocol and adjusting for GC content. CNVs were then 
excluded if they were covered by <3 probes. After CNV merging, the remaining CNVs were 
visually re-evaluated using the GenomeStudio genotyping module. cnvPartition was used as 
the secondary CNV detection algorithm using the default parameters. All CNV coordinates 
are according to UCSC build 37/hg19. 
Computational validation by ExomeDepth 
CNVs called by PennCNV and cnvPartition, were corroborated by computational validation 
with ExomeDepth. CN calls that were shared by all three calling algorithms (PennCNV, 
cnvPartition, and ExomeDepth) were considered high-confidence CNVs. 
The read count information was extracted from the individual BAM files using the R package 
Rsamtools. All reads were paired-end. Only reads with a Phred scaled mapping quality ≥20, 
distance of <1000bp from each other and in the correct orientation, were included. The 
location was defined by the middle location between the extreme ends of both paired reads. 
Exons closer than 50bp were merged into a single location owing to the inability to properly 
separate reads mapping to either of them. Parameters for ExomeDepth were applied 
according to the instructions provided by the user guide. 
Results 
Identifying discordant variants 
WES data were analysed by VarScan2 and MuTect2, using the annotated variant and 
genotype attained by the Haplotype Caller-based analysis as reference, to explore the possible 
occurrence of low-frequency variants compatible with a mosaicism state. As there is a 
possibility of the unaffected twin having a de novo variant that is not present in the affected 
twin, a reverse pairwise analysis was also performed where the affected twin was classified 
as the ‘normal’ sample and unaffected twin as the ‘tumour’ sample (Supplementary Tables 4 
and 5). The resulting discordant variants were further filtered by excluding those variants that 
were likely to be non-functional, e.g., synonymous variants and/or variants outside the exonic 
regions. There are exceptions to this rule, such as for the twin pair discordant for lactase non-
persistence (KEL and KIR), where causally-linked variants have been reported in intronic 
regions, with an MAF greater than 0.01.26 
After applying our stringent filtering criteria, twenty putative discordant variants were 
identified across all 13 twin pairs (Supplementary Table 6). However, only five of these 
variants could be validated with Sanger sequencing (Table 2), including a somatic variant in 
the PLCB1 gene in the twin affected with lactase non-persistence (KEL and KIR) and 
variants in four genes (TMEM225B, KBTBD3, TUBGCP4, TFIP11) in the unaffected twin of 
an ALS-discordant pair (242 and 243 (Figure 1). The success rate of 20% is due in part to 
the limited sensitivity of Sanger sequencing to detect alleles with a frequency of less than 
15%.27 A comparison of saliva and blood tissues for the twin pair discordant for ischaemic 
stroke did not reveal any evidence of somatic mosaicism. 
Identifying shared function-altering variants 
To test the hypothesis that the same rare, dominant or recessive variants could contribute to 
the phenotype for given twin pairs where no discordant variant was found, all potentially 
damaging shared exonic variants were examined, including known disease-associated loci 
that could explain disease onset according to a model taking into account the possibility of 
incomplete penetrance or variable expressivity. 
After application of the filtering criteria (see Materials and Methods), each twin pair shared 
approximately 200 rare variants that are predicated to affect protein function. These were 
screened against lists of disease-specific susceptibility genes, which were obtained from 
various databases, including PubMed, OMIM, NIH GTR, DisGeNET, DISEASES, ALSoD, 
ALSGene, PDGene, SZDB, and SZGene. This produced a total of 113 variants for the entire 
cohort. These variants were further reduced by removing those found in multiple other 
samples, repetitive sequences or systematic mismapping of paralogous sequences. Variants 
that were unambiguous upon manual inspection in IGV were retained. In total, 23 shared 
variants were identified in known disease-susceptibility genes. These variants with their 
functional categories are shown in Table 3. Considering that the shared variants between co-
twins were absent in all other samples, it would be extremely unlikely to obtain false-
positives in the same gene location in both twin siblings.  
Parent-offspring trio analysis 
The availability of parental DNAs for two pairs of twins discordant for ASD and Tourette’s 
syndrome respectively, allowed us to further investigate the origin of the shared variants. A 
total of 217,290 variants were called in GATK’s joint analysis in the entire cohort. Variants 
shared by the MZ twins, but absent in their parents’ blood samples and in the other twins, 
were considered to be de novo germline variants of parental origin. After applying this initial 
exclusion criteria, a total of 424 and 412 putative de novo SNVs and indels were detected in 
the two twin pairs discordant for ASD and Tourette’s syndrome, respectively. These variants 
were filtered using the same parameters set for postzygotic de novo variant detection. Upon 
manual review in IGV, variants could be further excluded on the basis that they were 
miscalled in one of the parents.  
A nonsynonymous variant in RASD2, a gene encoding for a GTP-binding protein Rhes on 
chromosome 22 (NM_014310.3:c.170G>A:p.(Arg57His)), was found in the twins with ASD 
discordant for severity. This variant is not reported in the dbSNP, 1000 Genomes, cg69 nor in 
the in-house database of 6,000 exomes. In the ExAC database containing more than 60,000 
human exome data, the variant was found with an allele frequency of 8.13E-06 in the total 
population (allele count of 1/121112). The variant is also highly conserved across multiple 
species and predicted to be deleterious in online available bioinformatics tools.21–23  
No shared de novo variant of parental origin was detected in the twins discordant for 
Tourette’s syndrome after application of our stringent filtering criteria described above. 
Nevertheless, as the father of the twins also had the condition, it is likely that both twins had 
inherited variants associated with the disorder. We focused our attention on variants 
consistent with a dominant mode of inheritance – namely, variants that are homozygous or 
heterozygous in the affected father, absent in the mother, and heterozygous in the twins. 
After filtering for rare or novel variants that were predicted to be damaging by at least one of 
the pathogenicity prediction tools led to the identification of 41 variants inherited from the 
father. Only one of these variants have previously been implicated in Tourette’s syndrome, 
from our comprehensive list of 138 genes mined from various databases and search of 
literature. This stop loss variant in AADAC, a gene encoding for arylacetamide deacetylase on 
chromosome 3 (NM_001086.2:c.1198T>C:p.(*400Glnext*1)), plus the de novo variant 
associated with ASD, were validated with Sanger sequencing in the two families (Figure 2). 
Mitochondrial DNA analysis 
We next tested the hypothesis that different levels of mtDNA heteroplasmy might account for 
the phenotypic discordance between the twins. After applying a minimum read count 
threshold of 10, a total of 399 shared and discordant variants were identified between the 
twins. These variants included 34 heteroplasmic variants and 365 homoplasmic variants. A 
total of 36 variants unique to either the affected or unaffected twin were verified using IGV. 
Among these, 23 were distributed on 12 genes throughout the mitochondrial genome, and 8 
were localised at the hypervariable segments HV1 (16024–16383) and HV2 (57–372). Most 
of the discordant variants came from the twin pair 421 and 422. These samples were excluded 
from further analysis due to the likelihood of artefacts created from high passage transformed 
immortalised cell lines. Variants in hypervariable segments were also removed. A novel 
nonsynonymous variant in MT-ND5 (m.1260C>A:p.(Ser420Arg)), the complex I 
mitochondrial gene, was detected in the unaffected twin SUS, but was absent in the co-twin 
affected with ALS, suggesting it might play a protective role. Although this discordant 
variant had a high depth of coverage (with the number of reads ranging from 130 to 220), it 
could not be excluded or confirmed with Sanger sequencing due to a low allele fraction of 
9%. 
Copy number variant analysis 
CNVs were initially called in PennCNV if they are covered by ≥3 probes in order to detect 
small CNVs that would potentially be filtered out of the data. As this is expected to result in a 
higher frequency of false positive calls, CNVs were also called using cnvPartition, and CN 
segments were only included in further analysis if the CN calls agreed between both 
algorithms. The results obtained from SNP array analysis are summarised in Supplementary 
Table 7. Putative CNVs were further confirmed against WES CNV calls using ExomeDepth. 
CN calls that were shared by all three calling algorithms were considered for downstream 
analysis (Table 4). 
For the CNVs shared between co-twins, we focused on subsets of genes that are associated 
with known phenotypes in disease databases such as OMIM and DisGeNET, or genes that are 
intolerant to LoF variants based on the Residual Variation Intolerance Score (RVIS) or the 
probability of being loss-of-function intolerant (pLI).28 An RVIS <0.0 means that a given 
gene has less common functional variation than expected, and is referred to as ‘intolerant’; 
whereas an RVIS >0.0 indicates that a gene has more common functional variation than 
expected. Genes with high pLI scores (pLI ≥ 0.9) are extremely LoF intolerant, whereas 
genes with low pLI scores (pLI ≤ 0.1) are LoF tolerant (Table 4). 
No CNV differences between co-twins or tissue types were found. However, four CNVs of 
parental germline origin were identified by the CN calling algorithms used but were not 
experimentally validated. Three were found to not overlap any genes or regulatory regions, 
and one was a CNV duplication found in the twins exhibiting signs of ASD (OH and RP) but 
differing in severity and overlapping >85% proximal of CD38. This shared de novo CNV was 
also called by ExomeDepth. 
The 138kb deletion in 15q13.2 spanning ARHGAP11B in the schizophrenia-discordant twins 
RT1a/RT1b was of particular interest as gene ontology terms include cerebral cortex 
development. CNV deletions containing ARHGAP11B have previously been associated with 
schizophrenia29 in numerous studies. The twins are discordant as the co-twin of the proband 
was diagnosed with schizotypal personality disorder. 
Discussion 
We report the successful detection of genomic differences between phenotypically discordant 
MZ twins. Numerous studies have failed to find somatic variants using NGS technology 
between discordant twins, with variants often masked by a substantial number of false 
positives. Such studies include twins discordant for multiple sclerosis,30 Crohn’s disease,31 
congenital hypothyroidism,32 and ALS.33 By taking a union of MuTect2 and VarScan2 to 
identify somatic variants, we offer a proof of concept for assessing the genetic aetiology of 
complex traits in discordant twins. A comparison of variant detection tools showed that 
MuTect2 identifies more low coverage somatic variants and has excellent capability in both 
control of false calls and discovery of potential true positives. VarScan2 was as efficient in 
low-frequency variants detection but exhibited an advantage in discovering somatic SNVs 
with relatively high frequencies, which makes it a beneficial supplement of MuTect2.34 
Our data suggest new variants are relatively common and involve a variety of pre and 
postzygotic mechanisms affecting nuclear and mitochondrial genes, including epistasis. For 
some of the twin pairs, no discordant variants were identified, and the shared variants present 
in disease-susceptibility genes do not readily explain the twins’ discordant phenotypes. We 
postulate discordance could be explained by shared pathogenetic variants resulting in 
incomplete penetrance or variable expressivity followed by secondary genetic or epigenetic 
changes affecting gene regulation. Other potential contributory factors might involve tissue-
specific somatic mutations. 
Discordant single nucleotide and indel variants 
A somatic frameshift deletion in PLCB1 was detected in a buccal sample, containing 
epithelial cells of common developmental origin to the cells lining the gut, derived from the 
affected twin with lactase non-persistence. PLCB1 is highly expressed in the cardia and 
colon, and in dairy cows this protein has been shown to hydrolyse most of the lipid 
phosphorus in the low- and high-density lipoprotein fractions of milk.35 However, the role of 
this gene in digestive system disorders remains unclear, but warrants further investigations to 
verify the significance of this variant, if any, in lactase non-persistence. 
In the ALS-discordant pair, two discordant nonsynonymous variants were identified in 
KBTBD3 and TUBGCP4, and two frameshift deletions in TMEM225B and TFIP11 (Table 2). 
Although these variants were predicted to disrupt protein function, this cannot be reconciled 
with the fact that they were detected in the unaffected twin. Nevertheless, it is possible that 
these somatic variants contributed to the phenotypic discordance by having protective effects 
in the unaffected twin. It is important to note that the DNA samples used for this pair are 
LCL-derived, and de novo mutations are known to be caused by the cell line transformation 
and culturing. However, several studies have suggested low-passage LCLs to be an 
appropriate representation of the donor’s genome.36 Nevertheless, we acknowledge that 
independent validation on DNA from uncultured sources is ideal. 
Shared single nucleotide and indel variants 
We examined shared variants with predicted pathogenicity. This included rare homozygous 
and heterozygous variants, and those in known disease-susceptibility genes.  
De novo variant detection in parent-offspring trio analysis 
Autism spectrum disorder 
A nonsynonymous variant (NM_014310.3:c.170G>A:p.(Arg57His)) of parental germline 
origin within the RASD family member 2 (RASD2) gene was found in both twins with a 
suspected diagnosis of ASD and behavioural problems (OH and RP) but showing different 
degrees of severity. RASD2 belongs to the Ras superfamily of small GTPases and is enriched 
in the striatum and involved in the modulation of dopaminergic neurotransmission.37 RASD2 
is located on chromosome 22q12.3, a region that harbours numerous susceptibility loci for 
psychosis,38 and has been suggested to be a vulnerability gene for neuropsychologically 
defined subgroups of schizophrenic patients.39 Currently, the co-twin has not been diagnosed 
but anecdotally has been showing clinical features of ASD. 
Tourette's syndrome 
No function-altering germline de novo variants were identified in the twin pair. However, a 
shared novel stop loss variant in AADAC, a gene encoding for arylacetamide deacetylase on 
chromosome 3 (NM_001086.2:c.1198T>C:p.(*400Glnext*1)), was inherited from the father. 
In a meta-analysis of 1181 patients and 118,730 control subjects, Bertelsen et al.40 determined 
a significant association between AADAC and Tourette’s syndrome. Further, functional 
studies demonstrated that AADAC is expressed in several brain regions previously implicated 
in the pathophysiology of Tourette’s syndrome, including the Purkinje cell layer of the 
human cerebellum.40 CNVs overlapping AADAC are the first to be successfully associated 
with Tourette’s syndrome. More recently, Yuan et al.41 found that variants in AADAC may be 
a candidate factor for Tourette’s syndrome development in a Han Chinese cohort. 
Transcriptome profiling data from The BrainSpan Atlas of the Developing Human Brain 
(http://www.brainspan.org) illustrates that AADAC expression peaks in the striatum between 
birth and adolescence. This is consistent with the typical clinical time course of tic onset, and 
indeed the age of onset of Tourette’s syndrome in the father and the affected twin 
investigated herein. However, other mechanisms such as epigenetics must be considered to 
explain the asymptomatic twin. Considering the above evidence, the stop loss variant 
detected in the father and twins warrants functional studies to investigate the role of AADAC 
in the pathogenesis of this disorder. 
Copy number shared variants 
A shared de novo CNV duplication of parental germline origin was detected in twins with a 
suspected diagnosis of ASD (discordant for severity), overlapping CD38, a gene implicated 
in ADHD,42 social memory, amnesia and ASD.43 Although our results don’t prove CNV 
contribution to phenotypic MZ discordance, the pre-twinning structural events detected in 
this twin cohort could represent a susceptible genetic background (Table 4). 
Schizophrenia 
A deletion in ARHGAP11B (CN = 1) and a duplication in ARHGAP5 (CN = 3) were 
identified in schizophrenia-discordant twin pairs RT1a/RT1b and IP16/IP17, respectively 
(Supplementary Figures 7 and 8). Although RT1b was diagnosed with schizophrenia, his co-
twin (RT1a) had schizotypal personality features.  
The ARHGAP5 gene product (a GTPase-activating protein for Rho family members) is linked 
to Ras, and thus to EGF receptor-mediated proliferation, migration and differentiation of 
forebrain progenitors.44 Therefore, an ARHGAP5 duplication in an MZ twin pair discordant 
for schizophrenia might point to an aetiological basis, because schizophrenia has been linked 
to altered prenatal neurogenesis of cortical neurons.45 In addition, ARHGAP5 and 
ARHGAP11B are contained within regions 14q12 and 15q13.2, respectively, which have 
previously been associated with schizophrenia.46,47 
ARHGAP11B, resides on chromosome 15q13.2, one of the most complex and unstable loci in 
the human genome. Several neurodevelopmental disorders have been linked to structural 
variants in this and nearby regions.48 ARHGAP11B arose from partial duplication of 
ARHGAP11A in the human lineage, approximately one million years after divergence from 
chimpanzees, but before divergence from Neanderthals.49 This led to the formation of large 
and complex human-specific segmental duplications, mediating recurrent rearrangements 
contributing to 15q13.3 microdeletion syndrome associated with intellectual disability, 
epilepsy and schizophrenia.50 ARHGAP11B is, to date, the only human-specific gene shown 
to promote basal progenitor generation and proliferation, including cortical plate 
augmentation and gyrification induction, and has been proposed to play an important role in 
the evolutionary expansion of the human neocortex.49 
The duplicated 8 exons of ARHGAP11A are almost identical to the paralogous sequence of 
ARHGAP11B, and thus not completely queried in high throughput genetic studies at the same 
locus and may have been mixed complex rearrangements. Indeed, variations in this region 
have flown below the radar of available genome-wide technologies, which likely has 
downplayed its hypothesised associations with neurodevelopmental disorders. Because of the 
genomic complexity of the region, the extent of human structural diversity and breakpoints of 
most rearrangement events are poorly understood at the molecular genetic level. Moreover, 
the wide expression of ARHGAP11B, its multiple functions and modes of regulation – not to 
mention its absence in other species – present challenges for its study in disease. 
Several RhoGAPs have been linked to schizophrenia. For example, a study reported an 
association between variation in ARHGAP32, which encodes a neuron-associated GTPase-
activating protein, and schizophrenia and schizotypal personality traits.51 ARHGAP33 
regulates synapse development and autistic-like behaviour.52 A missense polymorphism in 
ARHGAP3 has been associated with schizophrenia in men.53 Further, in a genome-wide 
association study from the Han Chinese population, Wong et al.54 identified a schizophrenia 
susceptibility locus on Xq28, which harbours the gene ARHGAP4. This study shows 
segmental duplications play an important role in normal variation as well as in genomic 
disease defining hotspots of rearrangement that are susceptible to variation among the normal 
population. Considering the above findings, we propose that both ARHGAP5 and 
ARHGAP11B are potentially associated with neuropsychiatric disorders, and this preliminary 
study provides the necessary baseline to begin future studies on disease populations. 
Conclusion 
We have successfully identified pre and postzygotic variants in twin pairs discordant for 
complex traits. Parent-offspring trio analysis revealed a novel candidate gene for ASD and a 
novel variant in a gene implicated in Tourette’s syndrome. 
This study also sheds new light on the genetics of complex disorders including lactase non-
persistence, ALS and schizophrenia. We show de novo variants are relatively common, could 
involve multiple genes and invoke multiple mechanisms affecting both nuclear and 
mitochondrial genes. We also show that discordant MZ twins may share common underlying 
variants and postulate that additional genetic events, such as epigenetic changes, might lead 
to phenotypic discordance. Thus, previous studies, mostly based on the premise of a de novo 
mutation in the affected twin, may have missed the opportunity to detect shared variants 
originating from the parents. Of note, we document a shared pathogenic hexanucleotide 
repeat expansion in the ALS-discordant twin pair 421 and 422 (see Supplementary Material), 
which have been previously reported.55 However, we haven’t been able to follow up these 
and other twins to determine whether there may be delayed onset in the ‘unaffected’ co-twin. 
In light of this, it would be worthwhile to re-evaluate earlier twin studies. In addition, 
functional validation of the variants reported herein is warranted, a lack of which is 
acknowledged as a limitation. 
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Titles and Legends to Figures 
Figure 1. IGV screenshots and electropherograms confirming somatic variation in twins 
discordant for ALS (242 and 243) and lactase non-persistence (KEL and KIR).  
Figure 2. IGV screenshots and electropherograms confirming a germline de novo and 
inherited variants. a. A parental germline de novo variant in RASD2 in twins with behavioural 
issues and ASD (OH and RP), which is absent in their parents (DS and DV). b. A stop loss 
variant detected in AADAC in twins discordant for Tourette’s syndrome, inherited from the 
affected father. 
 
    Proband (242)                  MZ twin (243)                        
TMEM225B: wild-type TMEM225B: c.582delG KBTBD3: wild-type KBTBD3: c.890A>G TUBGCP4: wild-type TUBGCP4: c.794C>T 
TFIP11: wild-type TFIP11: c.2453delA PLCB1: c.629delA PLCB1: wild-type 
  Proband (242)                 MZ twin (243)                             Proband (242)                 MZ twin (243)                        
    Proband (242)                   MZ twin (243)                           Proband (KEL)                 MZ twin (KIR)                        
- ALS - 
- ALS - - ALS - - ALS - 
- Lactase non-persistence - 
   Father (DS)                    Mother (DV)                   Proband (RP)                  MZ twin (OH) 
 Father (487)                     Mother (488)                 Proband (490)                 MZ twin (489) 
a. 
b. 
AADAC: c.1198T>C AADAC: wild type AADAC: c.1198T>C AADAC: c.1198T>C 
RASD2: c.170G>A RASD2: c.170G>A RASD2: wild-type RASD2: wild-type 
- ASD - 
- Tourette’s syndrome - 
Subject Status Diagnosis Sex Age Age of onset Ethnicity DNA source 
LAS Proband ALS F Died at 71 67 Caucasian Saliva 
SUS MZ twin - F 75 - Caucasian Saliva 
        
218 Proband ALS M 54 50 Caucasian LCL 
318 MZ twin - M 54 - Caucasian LCL 
        
421 Proband ALS F 58 55 Caucasian LCL 
422 MZ twin - F 58 - Caucasian LCL 
        
242 Proband ALS M 35 34 Caucasian LCL 
243 MZ twin - M 35 - Caucasian LCL 
        
KG(s) Proband Ischaemic stroke F 62 56 Caucasian Saliva KG(b) Blood 
        
HG(s) MZ twin - F 62 - Caucasian Saliva HG(b) Blood 
        
KEL Proband LNP F 23 5 Caucasian Saliva 
KIR MZ twin - F 23 - Caucasian Saliva 
        
AFF Proband IBM M 68 66 Caucasian Blood 
UNAFF MZ twin - M 68 - Caucasian Blood 
        
DS Father - M UN - Caucasian Saliva 
DV Mother - F UN - Afro-Caribbean Saliva 
RP Proband ASD M 10 7 Mixed Saliva 
OH MZ twin ASD? M 10 - Mixed Saliva 
        
487 Father TS, OCD, ADHD M 44 6 American Indian Blood 
488 Mother - F 44 - Caucasian Blood 
489 MZ twin - M 15 - Mixed Blood 
490 Proband TS M 15 7 Mixed Blood 
        
PD821 Proband PD M 40 30 Caucasian Blood 
PD161 MZ twin - M 40 - Caucasian Blood 
        
VF Proband HSP F 46 34 Caucasian Blood 
LF MZ twin HSP? F 46 - Caucasian Blood 
        
RT1a MZ twin SCPD M UN UN Asian Blood 
RT1b Proband SCZ  M UN UN Asian Blood 
        
IP16 Proband SCZ M UN UN Caucasian Saliva 
IP17 MZ twin - M UN - Caucasian Saliva 
 
Table 1. Clinical characteristics and demographic information on the MZ twin cohort. 
Abbreviations: ADHD = Attention deficit hyperactivity disorder; ALS = amyotrophic lateral 
sclerosis; ASD = Autism spectrum disorder; HSP = hereditary spastic paraplegia; IBM = 
inclusion body myositis; LNP = lactase non-persistence; OCD = obsessive compulsive 
disorder; PD = Parkinson’s disease; SCPD = schizotypal personality disorder; SCZ = 
schizophrenia; TS = Tourette’s syndrome; UN = unknown. 
 
 
 
 
 
 
 
  
Table 2. Sanger sequencing-validated discordant variants with corresponding allele fractions and functional annotations. Coordinates refer to 
human genome build UCSC hg19/GRCh37.  
 
Twin pair Gene Region Type Chr Position 
Genotype Depth of coverage (proband) Variant 
frequency 
(proband) 
Depth of coverage 
(MZ twin) Variant 
frequency 
(MZ twin) 
Reference Variant Reference Variant Reference Variant 
242 and 243 TMEM225B Exon Frameshift deletion 7 99208104 G - 11 0 0% 15 9 38% 
KBTBD3 Exon Nonsynonymous 11 105924526 A G 20 0 0% 45 7 14% 
TUBGCP4 Exon Nonsynonymous 15 43678059 C T 20 0 0% 43 15 26% 
TFIP11 Exon Frameshift deletion 22 26888040 A - 70 0 0% 83 48 36% 
KEL and KIR PLCB1 Exon Frameshift deletion 20 8637865 A - 37 12 26% 60 0 0% 
Twin pair Gene Region Type Chr Position RefSeq accession number c.DNA position Amino acid change 
LAS and SUS CNTN6 5’UTR n/a 3 1134367 NM_014461.2 c.-529G>A n/a 
 CRIM1 Exonic Nonsynonymous 2 36737128 NM_016441.2 c.1504G>A p.(Glu502Lys) 
218 and 318 AMPH Exonic Nonsynonymous 7 38574539 NM_001635.3 c.142C>T p.(Arg48Trp) 
 INA Exonic Nonsynonymous 10 105038008 NM_032727.3 c.1040A>G p.(His347Arg) 
242 and 243 DOC2B Exonic Nonsynonymous 17 11873 NM_003585.5 c.637C>T p.(Arg213Tyr) 
 HFE Exonic Nonsynonymous 6 26093125 NM_139010.3 c.829G>A p.(Glu277Lys) 
 VAPB Exonic Nonframeshift deletion 20 57016040 NM_004738.4 c.479_481del p.(Ser160del) 
KEL and KIR LCT 3’UTR n/a 2 136545844 NM_002299.4 c.*50G>C n/a 
 LCT Exonic Nonsynonymous 2 136555659 NM_002299.4 c.4916A>G p.(Asn1639Ser) 
 LCT Intronic n/a 2 136570613 n/a n/a n/a 
 LCT Intronic n/a 2 136590558 n/a n/a n/a 
 GLB1L Intronic n/a 2 220108217 n/a n/a n/a 
PD821 and 
PD161 HTR6 Exonic Nonsynonymous 1 20005151 NM_000871.1 c.806C>T p.(Thr269Met) 
 Table 3. Shared variants in known disease-linked genes. Coordinates refer to human genome build UCSC hg19/GRCh37.  
 
 
 
 
 
 UNC5C Exonic Nonsynonymous 4 96141217 NM_003728.3       c.1219C>T p.(Arg407Cys) 
LF and VF ZFR2 Exonic Nonsynonymous 19 3834902 NM_015174.1 c.133G>A p.(Val45Met) 
490 and 489 AADAC Exonic Stop loss 3 151545958 NM_001086.2 c.1198T>C p.(*400Glnext*1) 
 PDLIM5 Exonic Nonsynonymous 4 95585202 NM_001011513.3 c.1448A>G p.(His483Arg) 
RP and OH DPP6 Exonic Nonsynonymous 7 154519496 NM_001936.3 c.596A>G p.(Asn199Ser) 
 CHD7 Exonic Nonsynonymous 8 61777986 NM_017780.3       c.8488G>A p.(Ala2830Thr) 
RT1a and RT1b SEMA6C Exonic Nonsynonymous 18 151106475 NM_001178062.1 c.1696C>T p.(Pro566Ser) 
 GABRR3 Exonic Unknown 3 97753727 NR_047685.1 n.222C>T Unknown 
 PCLO Exonic Nonframeshift insertion 7 82784833 NM_014510.2 
c.1123_1124insC
TCTTGGTCCTG
CTAAGCCTCC
AGCTC 
p.(Gln374_Gln375i
nsProLeuGlyProAl
aLysProProAla) 
IP16 and IP17 VLDLR Exonic Nonsynonymous 9 2645718 NM_003383.3 c.1457C>G p.(Ala486Gly) 
 
Diagnosis of affected 
twin Gene 
Copy 
number (1 = 
deletion; 2 = 
duplication) 
Description Disease association (DisGeNET and DISEASES) RVIS pLI %HI 
ALS LARGE1 2 LARGE xylosyl- and glucuronyltransferase 1 
Congenital muscular dystrophy; 
mental retardation syndromes; -1.11 (10.98%) 0.96 4.10 
HSP SLC8A1 1 Solute carrier family 8 member A1 Myocardial ischemia; status 
epilepticus 
-1.41 (6.88%) 0.99 6.09 
Ischaemic stroke ELOVL6 2 ELOVL fatty acid elongase 6 Heart failure; Psoriasis; obesity; 
atherosclerosis; atopic dermatitis 
-0.27 (36.97%) 0.97 3.68 
Lactose intolerance 
MBD3L2 2 
Methyl-CpG binding domain protein 3 
like 2 Stomach neoplasms n/a n/a 95.74 
ADGRE4P 2 Adhesion G protein-coupled receptor 
E4, pseudogene 
Colorectal cancer n/a n/a n/a 
ADGRE1 2 Adhesion G protein-coupled receptor E1 
Liver cirrhosis; secondary 
periodontitis 2.21 (97.76%) 0.00 90.69 
ASD CD38 2 CD38 molecule Autism spectrum disorders 0.47 (70.44%) 0.00 77.57 
Tourette’s syndrome TOP3B 2 DNA topoisomerase III beta Cognitive impairment; schizophrenia -0.34 (33.91%) 0.11 15.86 
Tourette’s 
syndrome/Parkinson’s 
disease 
NLGN1 2 Neuroligin 1 
Autistic disorder; schizophrenia; 
bipolar disorder; depression; 
memory impairment 
-1.26 (8.92%) 0.76 1.37 
Inclusion body myositis 
AUTS2 2 AUTS2, activator of transcription and 
developmental regulator 
Neurological disorders; acute 
lymphoblastic leukaemia; aging of 
the skin; early-onset androgenetic 
alopecia; cancer 
-1.94 (3.32%) 1.00 0.51 
LILRB3 2 Leukocyte immunoglobulin like 
receptor B3 
Lung diseases; Takayasu's arteritis 0.79 (81.49%) 0.00 97.17 
Schizophrenia 
ARHGAP11
B 1 Rho GTPase activating protein 11B 
15q13.3 microdeletion syndrome; 
schizophrenia; bipolar disorder 0.07 (52.75%) 0.07 81.20 
ARHGAP5 2 Rho GTPase activating protein 5 Liver carcinoma; breast cancer -1.31 (8.10%) 0.99 8.15 
 
Table 4. Genes within CNV regions identified by PennCNV, cnvPartition and ExomeDepth. Genes that are in the RefSeq database 
(http://www.ncib.nlm.nih.gov/gene) and Ensembl database (http://www.ensembl.org) are reported. RVIS v4 is constructed on the ExAC v2 data 
release. Web resources DisGeNET and DISEASES were used to gather disease-gene associations from various expert curated databases and 
text-mining derived associations. 
 
